Thus, the molecular mechanism of carboplatin resistance occurs through the regulation of Mcl-1 and c-FLIP by the elevation of Nrf2-dependent PSMA5 expression in glioma cells. This evidence concerns the gene MCL1 and central nervous system cancer.